Christopher A. Kroeger is CEO at MapLight Therapeutics, Inc. (MPLT). They have made 2 open-market trades across 1 company since 2026, most recently 2026-08-17.
CIK 0001658918
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MPLT | 1,269,600 | $9.7M |
Shares reported on the most recent Form 4, priced at the 2026-08-19 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MPLT | SELL | 2026-07-15 | 2026-07-17 | $36.87 | $5.4M | -60.5% | -70.4% | -78.8% |
| MPLT | SELL · 10b5-1 | 2026-05-18 | 2026-05-18 | $27.19 | $3.2M | +12.3% | +11.3% | -56.9% |
| MPLT | SELL · 10b5-1 | 2026-05-07 | 2026-05-11 | $28.47 | $1.9M | -0.4% | -5.9% | -58.8% |
| MPLT | SELL · 10b5-1 | 2026-05-04 | 2026-05-06 | $28.39 | $1.4M | -6.0% | -0.7% | -54.2% |
| MPLT | SELL | 2026-04-15 | 2026-04-17 | $27.16 | $521K | +1.5% | -11.0% | +24.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.